Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pulmonx (LUNG) Tax Provisions (2019 - 2025)

Historic Tax Provisions for Pulmonx (LUNG) over the last 7 years, with Q3 2025 value amounting to $128000.0.

  • Pulmonx's Tax Provisions fell 3600.0% to $128000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $463000.0, marking a year-over-year decrease of 3810.16%. This contributed to the annual value of $500000.0 for FY2024, which is 1243.43% down from last year.
  • According to the latest figures from Q3 2025, Pulmonx's Tax Provisions is $128000.0, which was down 3600.0% from $200000.0 recorded in Q2 2025.
  • Over the past 5 years, Pulmonx's Tax Provisions peaked at $248000.0 during Q4 2023, and registered a low of $40000.0 during Q2 2022.
  • Moreover, its 5-year median value for Tax Provisions was $128000.0 (2025), whereas its average is $138117.6.
  • As far as peak fluctuations go, Pulmonx's Tax Provisions soared by 100000.0% in 2021, and later crashed by 6000.0% in 2022.
  • Over the past 5 years, Pulmonx's Tax Provisions (Quarter) stood at $143000.0 in 2021, then skyrocketed by 72.03% to $246000.0 in 2022, then rose by 0.81% to $248000.0 in 2023, then dropped by 19.35% to $200000.0 in 2024, then plummeted by 36.0% to $128000.0 in 2025.
  • Its Tax Provisions stands at $128000.0 for Q3 2025, versus $200000.0 for Q2 2025 and $135000.0 for Q1 2025.